Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 616271, 10 pages
http://dx.doi.org/10.1155/2014/616271
Research Article

Epidemiologic Behavior and Estimation of an Optimal Cut-Off Point for Homeostasis Model Assessment-2 Insulin Resistance: A Report from a Venezuelan Population

1Endocrine and Metabolic Diseases Research Center, University of Zulia, Maracaibo 4001, Venezuela
2Institute of Clinical Immunology, University of Los Andes, Mérida 5101, Venezuela
3Institute of Biological Investigations, University of Zulia, Maracaibo 4001, Venezuela
4Pharmacology Department, Physiological Sciences Unit, University of Zulia, Maracaibo 4001, Venezuela
5Morphological Sciences Department, University of Zulia, Maracaibo 4001, Venezuela
6Lipid and Atherosclerosis Unit, Department of Medicine, IMIBIC/Reina Sofia University Hospital/University of Cordoba and CIBER Fisiopatología Obesidad y Nutrición (CIBEROBN), Institute of Health Carlos III, Córdova 14004, Spain

Received 3 July 2014; Revised 24 August 2014; Accepted 25 August 2014; Published 29 October 2014

Academic Editor: Hui-Qi Qu

Copyright © 2014 Valmore Bermúdez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Rojas, V. Bermúdez, E. Leal et al., “Insulinorresistencia e hiperinsulinemia como factores de riesgo para enfermedad cardiovascular,” Archivos Venezolanos de Farmacología y Terapéutica, vol. 27, pp. 30–40, 2008. View at Google Scholar
  2. P. Zimmet and G. Alberti, “The IDF definition: why we need a global consensus,” Diabetes, vol. 51, article 213, 2006. View at Google Scholar
  3. A. D. Karelis, D. H. St-Pierre, F. Conus, R. Rabasa-Lhoret, and E. T. Poehlman, “Metabolic and body composition factors in subgroups of obesity: what do we know?” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2569–2575, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Vogeser, D. König, I. Frey, H.-G. Predel, K. G. Parhofer, and A. Berg, “Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons,” Clinical Biochemistry, vol. 40, no. 13-14, pp. 964–968, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-P. Wang, F.-M. Chung, S.-J. Shin, and Y.-J. Lee, “Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance,” Review of Diabetic Studies, vol. 4, no. 2, pp. 77–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Jaquet, D. A. Trégouët, T. Godefroy et al., “Combined effects of genetic and environmental factors on insulin resistance associated with reduced fetal growth,” Diabetes, vol. 51, no. 12, pp. 3473–3478, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. P. Casaer, D. Mesotten, and M. R. C. Schetz, “Bench-to-bedside review: metabolism and nutrition,” Critical Care, vol. 12, no. 4, article 222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Ross and J.-P. Després, “Abdominal obesity, insulin resistance, and the metabolic syndrome: contribution of physical activity/exercise,” Obesity, vol. 17, no. 3, pp. S1–S2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Rojas, V. Bermúdez, E. Leal et al., “Origen étnico y enfermedad cardiovascular,” Archivos Venezolanos de Farmacología y Terapéutica, vol. 27, pp. 40–57, 2008. View at Google Scholar
  10. R. A. DeFronzo, J. D. Tobin, and R. Andres, “Glucose clamp technique: a method for quantifying insulin secretion and resistance,” American Journal of Physiology—Endocrinology Metabolism and Gastrointestinal Physiology, vol. 6, no. 3, pp. E214–E223, 1979. View at Google Scholar · View at Scopus
  11. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Levy, D. R. Matthews, and M. P. Hermans, “Correct homeostasis model assessment (HOMA) evaluation uses the computer program,” Diabetes Care, vol. 21, no. 12, pp. 2191–2192, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. T. M. Wallace, J. C. Levy, and D. R. Matthews, “Use and abuse of HOMA modeling,” Diabetes Care, vol. 27, no. 6, pp. 1487–1495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-F. Brun, E. Raynaud, and J. Mercier, “Homeostasis model assessment and related simplified evaluations of insulin sensitivity from fasting insulin and glucose,” Diabetes Care, vol. 23, no. 7, pp. 1037–1038, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Geloneze, E. M. Repetto, S. R. Geloneze, M. A. Tambascia, and M. N. Ermetice, “The threshold value for insulin resistance (HOMA-IR) in an admixtured population. IR in the Brazilian Metabolic Syndrome Study,” Diabetes Research and Clinical Practice, vol. 72, no. 2, pp. 219–220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Zadeh-Vakili, F. R. Tehrani, and F. Hosseinpanah, “Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women,” Diabetology and Metabolic Syndrome, vol. 3, article 18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. L. Garmendia, L. Lera, H. Sánchez, R. Uauy, and C. Albala, “Homeostasis model assessment (HOMA) values in chilean elderly subjects,” Revista Medica de Chile, vol. 137, no. 11, pp. 1409–1416, 2009. View at Google Scholar · View at Scopus
  18. G. Reaven, “The insulin resistance syndrome: past, present, and future,” in Proceedings of the 1st Annual World Congress on the Insulin Resistance Syndrome, Los Angeles, Calif, USA, November 2003.
  19. H.-Q. Qu, Q. Li, A. R. Rentfro, S. P. Fisher-Hoch, and J. B. McCormick, “The definition of insulin resistance using HOMA-IR for americans of mexican descent using machine learning,” PLoS ONE, vol. 6, no. 6, Article ID e21041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Bermúdez, M. Pacheco, J. Rojas et al., “Epidemiologic behavior of obesity in the Maracaibo city Metabolic Syndrome Prevalence Study,” PLoS ONE, vol. 7, no. 4, Article ID e35392, 2012. View at Google Scholar
  21. V. Bermúdez, J. Rojas, E. Córdova et al., “International physical activity questionnaire overestimation is ameliorated by individual analysis of the scores,” American Journal of Therapeutics, vol. 20, pp. 448–458, 2013. View at Google Scholar
  22. V. Bermúdez, J. Rojas, J. Salazar et al., “Variations of lipoprotein(a) levels in the metabolic syndrome: a report from the Maracaibo City metabolic syndrome prevalence study,” Journal of Diabetes Research, vol. 2013, Article ID 416451, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Bermúdez, R. P. Marcano, C. Cano et al., “The Maracaibo city metabolic syndrome prevalence study: design and scope,” American Journal of Therapeutics, vol. 17, pp. 288–294, 2010. View at Google Scholar
  24. National Health and Nutrition Examination Survey, NHANES Web Tutorial, http://www.cdc.gov/nchs/tutorials/nhanes/SurveyDesign/SampleDesign/Info1.htm.
  25. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 Report,” The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2571, 2003. View at Publisher · View at Google Scholar
  26. World Health Organization, “The World Health Report 2003,” http://www.who.int/whr/2003/en/.
  27. Health Statistics, “NHANES III reference manuals and reports (CDROM),” Centers for Disease Control and Prevention, Hyattsville, Md, USA, 1996, http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/NCHS/MANUALS/ANTHRO.PDF.
  28. K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  30. F. Conus, R. Rabasa-Lhoret, and F. Péronnet, “Characteristics of metabolically obese normal-weight (MONW) subjects,” Applied Physiology, Nutrition and Metabolism, vol. 32, no. 1, pp. 4–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. O. V. Demler, M. J. Pencina, and S. D'Agostino, “Misuse of DeLong test to compare AUCs for nested models,” Statistics in Medicine, vol. 31, no. 23, pp. 2477–2587, 2012. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  32. N. J. Perkins and E. F. Schisterman, “The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve,” The American Journal of Epidemiology, vol. 163, no. 7, pp. 670–675, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Geloneze, A. C. J. Vasques, C. F. C. Stabe et al., “HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome—Brazilian Metabolic Syndrome Study (BRAMS),” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 53, no. 2, pp. 281–287, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Buccini and D. L. Wolftbal, “Valores de corte para índices de insulinorresistencia , insulinosensibilidad e insulinosecreción derivados de la fórmula HOMA y del programa HOMA2,” The Revista Argentina de Endocrinología y Metabolismo, vol. 45, pp. 3–21, 2008. View at Google Scholar
  35. A. J. G. Hanley, K. Williams, M. P. Stern, and S. M. Haffner, “Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio heart study,” Diabetes Care, vol. 25, no. 7, pp. 1177–1184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Bonora, G. Formentini, F. Calcaterra et al., “HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study,” Diabetes Care, vol. 25, no. 7, pp. 1135–1141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Tchernof and J.-P. Després, “Pathophysiology of human visceral obesity: an update,” Physiological Reviews, vol. 93, no. 1, pp. 359–404, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. R. Ryder, S. Vega-López, C. S. Djedjos, and G. Q. Shaibi, “Abdominal adiposity, insulin resistance, and oxidized low-density lipoproteins in Latino adolescents,” Diabetology & Metabolic Syndrome, vol. 5, article 72, 2013. View at Google Scholar
  39. N. Sattar, K. Williams, A. D. Sniderman, R. D'Agostino Jr., and S. M. Haffner, “Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the insulin resistance atherosclerosis study,” Circulation, vol. 110, no. 17, pp. 2687–2693, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Shalaurova, M. A. Connelly, W. T. Garvey, and J. D. Otvos, “Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance,” Metabolic Syndrome and Related Disorders, 2014. View at Publisher · View at Google Scholar
  41. G. Kressel, B. Trunz, A. Bub et al., “Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk,” Atherosclerosis, vol. 202, no. 1, pp. 263–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. C. A. Vella, X. Burgos, C. J. Ellis et al., “Associations of insulin resistance with cardiovascular risk factors and inflammatory cytokines in normal-weight hispanic women,” Diabetes Care, vol. 36, no. 5, pp. 1377–1383, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Bermúdez, E. Rojas, J. J. Salazar et al., “Coronary risk estimation according to the Framingham-Wilson score: epidemiologic behavior of innovative cardiometabolic risk factors in the Maracaibo City,” International Journal of Cardiovascular Research, vol. 2, article 4, 2013. View at Publisher · View at Google Scholar
  44. H.-Q. Qu, Q. Li, Y. Lu, C. L. Hanis, S. P. Fisher-Hoch, and J. B. Mccormick, “Ancestral effect on HOMA-IR levels quantitated in an American population of Mexican origin,” Diabetes Care, vol. 35, no. 12, pp. 2591–2593, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. M. F. Seldin, C. Tian, R. Shigeta et al., “Argentine population genetic structure: large variance in Amerindian contribution,” The American Journal of Physical Anthropology, vol. 132, no. 3, pp. 455–462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. N. A. Johnson, M. A. Coram, M. D. Shriver et al., “Ancestral components of admixed genomes in a Mexican cohort,” PLoS Genetics, vol. 7, Article ID e1002410, 2011. View at Publisher · View at Google Scholar · View at Scopus